Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Br J Oral Maxillofac Surg ; 52(7): 641-6, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24894709

ABSTRACT

To evaluate the viability, efficacy, and safety of sialoendoscopy for the diagnosis and management of radioiodine I(131-) related sialoadenitis, we retrospectively reviewed 30 patients referred between September 2007 and July 2013 from the Thyroid Surgery Unit to the Maxillofacial Unit of the Second University of Naples Hospital with persistent sialoadenitis after treatment with I(131). After the affected gland had been isolated, the endoscope was introduced into the duct under local anaesthesia with 2% lignocaine and continuous lavage with isotonic saline, and was advanced until it reached the ductal system. We studied 24 women and 6 men, mean (SD) age 52 (??) years. In 25 patients I(131) was given for papillary (83%), in 3 for medullary (10%), and in 2 for follicular thyroid carcinoma (7%). Stenosis alone was found in 30 glands (40%), mucous plugs alone in 35 (47%), and mucous plugs, stenosis, and kinks in 10 (13%). Of the 75 glands, dilatation of the ducts was successful in 70, and we completely removed all mucous plugs and kinks. We achieved symptomatic improvement in 23 patients (77%) during a follow-up ranging from 2 weeks to 84 months. Sialoendoscopy is a viable technique for the diagnosis of obstructive salivary disease, and is a safe and effective way to treat sialoadenitis, the most common complication of treatment with I(131).


Subject(s)
Endoscopy/methods , Iodine Radioisotopes/adverse effects , Radiopharmaceuticals/adverse effects , Sialadenitis/therapy , Adenocarcinoma, Follicular/radiotherapy , Adult , Aged , Carcinoma, Medullary/radiotherapy , Constriction, Pathologic/etiology , Constriction, Pathologic/therapy , Dilatation/methods , Female , Follow-Up Studies , Humans , Male , Middle Aged , Mucus , Parotitis/etiology , Parotitis/therapy , Retrospective Studies , Salivary Ducts/pathology , Sialadenitis/etiology , Submandibular Gland Diseases/etiology , Submandibular Gland Diseases/therapy , Therapeutic Irrigation/methods , Thyroid Neoplasms/radiotherapy , Treatment Outcome
2.
Clin Exp Dermatol ; 37(5): 516-20, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22632105

ABSTRACT

BACKGROUND: Hyaluronic acid (HA) preparations are widely used in clinical practice to accelerate wound healing, but it is not clear whether HA can exert direct effects on epidermal keratinocytes. AIM: To investigate the molecular and functional changes induced by HA preparations in keratinocytes by measuring global gene expression and wound healing. METHODS: Human skin keratinocytes were used for this study. They were treated with either sodium hyaluronate (SH) alone or a commercial adjuvant gel (Aminogam(®)) containing SH in combination with a pool of synthetic amino acids (L-proline, L-leucine, L-lysine and glycine). Global gene expression of nearly 55,000 transcripts was investigated with a chip array (Affymetrix Human Genome U133 2.0 Plus). RESULTS: We found that keratinocytes expressed all major HA receptors at the transcriptional level. In a fibroblast-free system, both SH and the adjuvant gel could effectively promote wound healing of keratinocytes. Major gene expression changes induced by HA preparations involves proteolysis, proteinase inhibitors, cellular metabolism and cytoskeleton. In total, 21 genes were differentially transcribed by SH and the adjuvant gel. CONCLUSIONS: Keratinocytes represent a previously underestimated target for HA action in wound healing. HA preparations induce transcriptional changes in keratinocytes and stimulate wound closure. Furthermore, the addition of synthetic amino acids to SH induces a distinct transcriptional profile.


Subject(s)
Hyaluronic Acid/pharmacology , Keratinocytes/drug effects , Amino Acids/pharmacology , Cells, Cultured , Gene Expression Profiling , Gene Expression Regulation/drug effects , Humans , Microarray Analysis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Cell Surface/metabolism , Wound Healing/drug effects
3.
Int J Immunopathol Pharmacol ; 23(1): 143-51, 2010.
Article in English | MEDLINE | ID: mdl-20378002

ABSTRACT

Oral mucositis (OM) is a very frequent and potentially severe complication experienced by patients receiving chemotherapy and/or radiotherapy, which often leads to significant morbidity and mortality, and decreased quality of life, and is very costly. Despite its severity and prevalence, there is no standard recognised management today. The aim of this open clinical trial is to evaluate the efficacy and compliance of a new spray compound containing sodium hyaluronate (SH) and a pool of collagen precursor amino acids (AAs) combined with sodium hyaluronate (SH) to manage radio/chemotherapy-induced OM. Twenty-seven consecutive patients with OM were treated according to the manufacturers instructions. At time T0 (baseline before intervention), we evaluated the following parameters: (i) pain score (by linear visual analogue scale; 0100) and (ii) severity of OM scored according to WHO Mucositis scale. The treatment efficacy was evaluated on i) pain score, ii) clinical resolution index (CRI) and iii) patient compliance at times T01 (after 2 hours), T1 (after 24 hours), T2 (after 72 hours), T3 (after 7 days) and T4 (after 14 days). Results showed that painful symptoms were significantly reduced after only 2 hours of spray administration compared with baseline measurements (p less than 0.0001; z=-4.541). A progressive reduction of pain through the 2 weeks was also noted (p less than 0.0001). Patient lesions treated with SH-Asbased spray also significantly improved after 72 hours of treatment (p=0.0051; z=-2.803). During the two-week observation, all patients significantly improved from the baseline (p less than 0.0001) and progressively ameliorated their ability to swallow foods and liquids. The compliance of all patients to the product was very good, and at the end of the study there were no adverse effects. The results suggest that the SHAAs-based spray accelerates lesion healing and above all helps to manage mucositis pain, especially in terms of immediate pain relief (after 2 hours from application). Although further randomized controlled studies are recommended, our findings suggest that frequent applications of this spray may offer rapid and effective pain management, aiding faster mucosal wound healing.


Subject(s)
Amino Acids/administration & dosage , Antineoplastic Agents/adverse effects , Collagen/biosynthesis , Hyaluronic Acid/administration & dosage , Radiotherapy/adverse effects , Stomatitis/drug therapy , Adolescent , Adult , Aged , Aged, 80 and over , Female , Glycine/administration & dosage , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/radiotherapy , Humans , Leucine/administration & dosage , Lysine/administration & dosage , Male , Middle Aged , Pain Measurement , Proline/administration & dosage , Stomatitis/etiology
4.
Minerva Stomatol ; 50(5): 151-6, 2001 May.
Article in Italian | MEDLINE | ID: mdl-11420566

ABSTRACT

The goal of this study is to analyze the importance of circulating biomarkers association in the management of patients affected by oral cancer. In this study a survey is made of the international experience from 1980 to 1990 based on the presence of CEA, LASA, SCC Ag, TPA, ferritina, CA-50 and others in patients affected by oral cancer and the sensitivity and specificity of these circulating biomarkers association are assessed. In patients with active disease, the results obtained at the time of diagnosis of oral cancer are not satisfactory due to poor specificity of these circulating biomarkers association. The conclusions is drawn that the circulating biomarkers association (especially CEA, SCC Ag, LASA, ferritin, TPA and CA-50) appears to be useful in the prognosis and staging of oral cancer, while their presence is not significative for the diagnosis.


Subject(s)
Biomarkers, Tumor/blood , Mouth Neoplasms/blood , Follow-Up Studies , Humans , Sensitivity and Specificity
5.
Minerva Stomatol ; 49(7-8): 389-92, 2000.
Article in Italian | MEDLINE | ID: mdl-11234691

ABSTRACT

A case of angioleiomyoma localized at the level of the soft palate is reported. The 31-year-old patient presented a non-pathognomonic clinical picture and the anamnestic finding of the relatively slow growth of the neoformation raised problems of differential diagnosis in relation to benign growth and lesion of a non-neoplastic nature. The differential diagnosis was only obtained with histological examination of biopsy material.


Subject(s)
Angiomyoma/pathology , Palatal Neoplasms/pathology , Adult , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...